{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:54:38Z","timestamp":1790258078961,"version":"4.1.0"},"reference-count":80,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Tumor\u2010infiltrating lymphocytes (TILs) are B, T\u2010helper, and T\u2010cytotoxic lymphocytes migrated from the blood or lymph stream toward a tumor with the aim to infiltrate and destroy it. They can be histologically graded as brisk, nonbrisk, or absent. Malignant melanoma has been the first malignancy found to be correlated with TILs status, being brisk TILs associated with better clinical outcomes. By the terminology of \u201cadoptive cell transfer\u201d (ACT), the medical oncology refers to the transfer of cells in\u00a0a tumor\u2010bearing\u00a0patient from\u00a0the same recipient or a healthy donor.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A PubMed literature search on the topic has been performed. Additional documents known to the authors and identified from the reference list of cited publications have been included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the past, autologous TILs ACT was successfully tested for the treatment of malignant melanoma and, today, it is a standardized procedure in several centers around the world. It represents the first research step toward the bioengineered chimeric antigen receptor T (CAR\u2010T) cell therapy from autologous donor.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Both autologous TILs ACT and CAR\u2010T cell therapy from autologous donor exploit the anticancer power of targeted self\u2010lymphocytes, but CAR\u2010T cell technology also virtually allows treatment of those melanomas devoid of TILs or with so few cytotoxic TILs that are difficult to identify.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ijd.14945","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T09:49:22Z","timestamp":1590140962000},"page":"763-769","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Adoptive cell transfer (ACT) of autologous tumor\u2010infiltrating lymphocytes (TILs) to treat malignant melanoma: the dawn of a chimeric antigen receptor T (CAR\u2010T) cell therapy from autologous donor"],"prefix":"10.1111","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6949-2216","authenticated-orcid":false,"given":"Luca","family":"Roncati","sequence":"first","affiliation":[{"name":"Department of Medical and Surgical Sciences University Hospital of Modena Modena (MO) Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0871-138X","authenticated-orcid":false,"given":"Beniamino","family":"Palmieri","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences University Hospital of Modena Modena (MO) Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0000000000000457"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3909"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12253-015-0024-7"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2018_170404N246"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00168"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/LBR.0000000000000363"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2015.12.030"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.10.032"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/his.13168"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4287"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/CJI.0b013e31818403d5"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0116"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0000000000000301"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14023"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.13548"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2016.09.014"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0041"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-1177"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-169"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-112311-083918"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa4967"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20050732"},{"key":"e_1_2_6_24_1","unstructured":"US National Institute of Health National Cancer Institute. (2012)Immunotherapy using tumor infiltrating lymphocytes for patients with metastatic human papillomavirus\u2010associated cancers[WWW document].https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01585428[accessed on 7 March 2018]."},{"key":"e_1_2_6_25_1","unstructured":"US National Institute of Health National Cancer Institute. (2010)Immunotherapy using tumor infiltrating lymphocytes for patients with metastatic cancer[WWW document].https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01174121[accessed on 15 May 2019]."},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-7563.2010.01335.x"},{"key":"e_1_2_6_27_1","first-page":"341","article-title":"Microsatellite instability predicts response to anti\u2010PD1 immunotherapy in metastatic melanoma","volume":"26","author":"Roncati L","year":"2018","journal-title":"Acta Dermatovenerol Croat"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30607-1"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1129003"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1711886"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.06.004"},{"key":"e_1_2_6_32_1","first-page":"127","article-title":"Generation of effector T cells expressing chimeric T cell receptor with antibody type\u2010specificity","volume":"21","author":"Gross G","year":"1989","journal-title":"Transplant Proc"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0548"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12772"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2014.1"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201505869"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15851"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/cas.13239"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201607485"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-072843"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9689-9"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.aab4077"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1316026110"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/mto.2016.11"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom10020263"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11684-019-0714-8"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-703751"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85309"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-13-0006"},{"key":"e_1_2_6_50_1","unstructured":"US Food & Drug Administration. (2017)FDA approval brings first gene therapy to the United States[WWW document].https:\/\/www.fda.gov\/news\u2010events\/press\u2010announcements\/fda\u2010approval\u2010brings\u2010first\u2010gene\u2010therapy\u2010united\u2010states[accessed on 26 March 2018]."},{"key":"e_1_2_6_51_1","unstructured":"US Food & Drug Administration. (2017)FDA approves CAR\u2010T cell therapy to treat adults with certain types of large B\u2010cell lymphoma[WWW document].https:\/\/www.fda.gov\/news\u2010events\/press\u2010announcements\/fda\u2010approves\u2010car\u2010t\u2010cell\u2010therapy\u2010treat\u2010adults\u2010certain\u2010types\u2010large\u2010b\u2010cell\u2010lymphoma[accessed on 21 March 2018]."},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw2127"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.016"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12015-019-09901-7"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19361"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010125"},{"key":"e_1_2_6_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-36214-0_7"},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-018-0568-6"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-062315-120245"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02486"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2016.128"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1160809"},{"key":"e_1_2_6_63_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-019-00368-z"},{"key":"e_1_2_6_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.12.005"},{"key":"e_1_2_6_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.05.012"},{"key":"e_1_2_6_66_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1610497"},{"key":"e_1_2_6_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.03.010"},{"key":"e_1_2_6_68_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-14-1421"},{"key":"e_1_2_6_69_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-016-5023-8"},{"key":"e_1_2_6_70_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.0225"},{"key":"e_1_2_6_71_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-017-0440-4"},{"key":"e_1_2_6_72_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.0184"},{"key":"e_1_2_6_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13792"},{"key":"e_1_2_6_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/CMR.0b013e32832eabd5"},{"key":"e_1_2_6_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.14.1047"},{"key":"e_1_2_6_76_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-017-1612-1"},{"key":"e_1_2_6_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700545"},{"key":"e_1_2_6_78_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0022-202x.2001.01605.x"},{"key":"e_1_2_6_79_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds257"},{"key":"e_1_2_6_80_1","doi-asserted-by":"publisher","DOI":"10.4103\/0377-4929.162835"},{"key":"e_1_2_6_81_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0106-0"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijd.14945","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijd.14945","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ijd.14945","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijd.14945","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T03:14:25Z","timestamp":1693970065000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijd.14945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1111\/ijd.14945"],"URL":"https:\/\/doi.org\/10.1111\/ijd.14945","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]},"assertion":[{"value":"2019-12-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-21","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}